Public and scientific interest into psychedelic drugs has grown steadily over much of the last two decades, before an exponential increase in recent years. We contend that 2019, in particular, involved myriad notable changes in the science, industry, and deregulation of psychedelic drugs. However, it is becoming increasingly difficult for professionals to keep up-to-date on …
It is well documented that psychedelic drugs can have a profound effect on colour perception. After previous research involving psychedelic drug ingestion, several participants had written to the authors describing how symptoms of their colour blindness had improved. The Global Drugs Survey runs the world’s largest annual online drug survey. In the Global Drugs Survey …
This Drug Science research was published in the British Medical Journal Open, you can download the full report here. In November 2018 when the UK made cannabis-based products for medicinal use (CBPMs) legal most people assumed these would immediately be made available to patients, but they were wrong. In the year since almost no National …
Read the full paper here (open access) Drug Science submits it’s finding concerning the UK Medical cannabis industry. In our recent peer-reviewed publication, Drug Science examines the current barriers to prescribing medical cannabis; ethical issues that arise from that process and we present our recommendations for best practice within this space. In the UK, medical …
Call for Evidence – Part Two focused on prevention, treatment and recovery. Drug Science has submitted its findings to Dame Carol Black to be considered in Part 2 of her independent review of drugs. The full submission can be found here: Key Points of the Drug Science Submission (submitted on August 6th 2020) can …
This Parliamentary briefing has been prepared by DrugScience, The Global Drug Survey, Release and Transform Drug Policy Foundation. Recreational use of nitrous oxide Nitrous oxide is a gas that was discovered in the late 1800s by UK scientists Priestley and Davy, the latter being President of the Royal Society. At the time nitrous oxide …
Drug Science will launch the Working Medical Cannabis Working Group at its House of Lords annual evening reception on Wednesday 22 May 2019.
Mephedrone is the common name for 4-methylmethcathinone. This is a synthetic derivative of cathinone, first synthesized in 1929, and largely forgotten until the early 2000s when Israeli scientists working for an insecticide company started experimenting with cathinones as octopamine analogues to disrupt the brain activity of aphids so make them less damaging to plants. Mephedrone …
With the 2019 general election fast approaching, a lot of media coverage will focus on each party’s Brexit policies. Drug Science would like to offer a different perspective, what do the six highest polling parties promise to do to address the UK’s failing drug policy. This is what each party has publicly announced relating to …
Read the full paper here (open access) Drug Science submits it’s finding concerning the UK Medical cannabis industry. In our recent peer-reviewed publication, Drug Science examines the current barriers to prescribing medical cannabis; ethical issues that arise from that process and we present our recommendations for best practice within this space. In the UK, medical …
Drug Science stands by its e-cigarette analysis from 2014, any way of radically reducing the death toll from tobacco would be a worldwide public health triumph. e-cigarettes are not the solution to end the ever-increasing death toll caused by tobacco. However, they have proven to be an incredibly effective tool for tens of thousands of …
Read the full paper here (open access) We present the preliminary data in the Bristol-Imperial MDMA-for-Alcoholism (BIMA) study, an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder (AUD). At this stage, eleven participants have completed the full 8-week MDMA-assisted …
Project Twenty21 is committed to scientific excellence and the development of independent scientific evidence. It is supported by a scientific oversight board, consisting of the following expertise: Professor David Nutt DM, FRCP, FRCPSYCH, FSB, FMEDSCI. Professor of Neuropsychopharmacology at Imperial College London. Professor Eileen Joyce MA, PhD, MB BChir, MRCP, FRCPsych Professor of Neuropsychiatry at …
